CRISPR-Cas9: Neurotransmitter Editing Risks

By
mkexpress-smdhnq
-
0
115

CRISPR Cas9

CRISPR-Cas9 technology to edit genes associated with neurotransmitter production in adult human brains presents a range of potential long-term neurological implications. This gene-editing tool can target specific genes, which could lead to significant advancements in treating various neurological and psychiatric disorders. However, the impact of such interventions are complex and multifaceted.

Potential Long-Term Neurological Implications

1. Altered Neurotransmitter Levels and Functionality

Editing genes related to neurotransmitter production could directly influence neurotransmitters such as dopamine, serotonin, and glutamate levels and activity. While this could potentially alleviate symptoms of disorders like depression, schizophrenia, or Parkinson’s disease, it may also lead to:
  • Imbalance of Neurotransmitter Systems: Over- or under-production of neurotransmitters might disrupt the delicate balance required for normal brain function, potentially exacerbating conditions or leading to new neurological issues.
  • Neuroplasticity Changes: Long-term alterations in neurotransmitter levels can affect neuroplasticity—the brain’s ability to adapt and reorganize itself—which is crucial for learning and memory. Dysregulation might impair cognitive functions or emotional regulation over time

2. Risk of Off-Target Effects

CRISPR-Cas9 is imperfect; unintended edits (off-target effects) can occur. These unintended genetic modifications might lead to the following:

  • Unpredictable Behavioral Changes: Off-target effects could alter genes that are not the intended focus of treatment, potentially resulting in unexpected behavioral or cognitive changes.
  • Long-Term Genetic Stability: The stability of edited genes over time is uncertain. Changes may revert or lead to new mutations, raising concerns about the long-term efficacy and safety of such interventions

3. Immune Response and Neuroinflammation

Introducing CRISPR components into the brain could provoke an immune response:

  • Neuroinflammatory Reactions:

Foreign CRISPR components may trigger inflammation in the central nervous system (CNS), contributing to neuronal damage and exacerbating existing conditions.

  • Cellular Toxicity: The process of gene editing itself may induce stress responses in neurons, leading to cell death or dysfunction if not carefully controlled

4. Ethical and Psychological Considerations

The long-term implications also extend beyond biological effects:
  • Ethical Concerns: The ability to edit genes raises ethical questions regarding consent, especially in cases where cognitive functions are altered. The potential for misuse or unintended consequences must be carefully considered.
  • Psychological Impact: Changes in personality or cognitive abilities due to gene editing could have profound psychological effects on individuals, possibly affecting their identity and relationships

References

  1. Albinger, N., Hartmann, J. & Ullrich, E. Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany. Gene Ther. 28, 513–527 (2021).

    Article CAS PubMed PubMed Central Google Scholar

  2. Maude, S. L. et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N. Engl. J. Med. 378, 439–448 (2018).

    Article CAS PubMed PubMed Central Google Scholar

  3. Munshi, N. C. et al. Idecabtagene vicleucel in relapsed and refractory multiple myeloma. N. Engl. J. Med. 384, 705–716 (2021).

Conclusion
While CRISPR-Cas9 technology holds great promise for treating neurological disorders by targeting genes involved in neurotransmitter production, it is essential to approach its application cautiously.
The potential long-term neurological implications include altered neurotransmitter dynamics, risks of off-target effects, immune responses, and ethical considerations that must be thoroughly understood through rigorous research before clinical applications are widely adopted.

RELATED ARTICLESMORE FROM AUTHOR